Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Sci Rep ; 6: 28282, 2016 06 20.
Artículo en Inglés | MEDLINE | ID: mdl-27320846

RESUMEN

Prior research has shown that in experimental diabetes mellitus, green tea reduces albuminuria by decreasing podocyte apoptosis through activation of the WNT pathway. We investigated the effect of green tea polyphenols (GTP) on residual albuminuria of diabetic subjects with nephropathy. We conducted a randomised, double-blind study in 42 diabetic subjects with a urinary albumin-creatinine ratio (UACR) >30 mg/g, despite administration of the maximum recommended dose of renin-angiotensin (RAS) inhibition. Patients were randomly assigned to two equal groups to receive either GTP (containing 800 mg of epigallocatechin gallate, 17 with type 2 diabetes and 4 with type 1 diabetes) or placebo (21 with type 2 diabetes) for 12 weeks. Treatment with GTP reduced UACR by 41%, while the placebo group saw a 2% increase in UACR (p = 0.019). Podocyte apoptosis (p = 0.001) and in vitro albumin permeability (p < 0.001) were higher in immortalized human podocytes exposed to plasma from diabetic subjects compared to podocytes treated with plasma from normal individuals. In conclusion, GTP administration reduces albuminuria in diabetic patients receiving the maximum recommended dose of RAS. Reduction in podocyte apoptosis by activation of the WNT pathway may have contributed to this effect.


Asunto(s)
Albuminuria/tratamiento farmacológico , Catequina/análogos & derivados , Nefropatías Diabéticas/tratamiento farmacológico , Pisum sativum/química , Polifenoles/administración & dosificación , Anciano , Albuminuria/metabolismo , Albuminuria/patología , Apoptosis/efectos de los fármacos , Catequina/administración & dosificación , Catequina/química , Células Cultivadas , Nefropatías Diabéticas/metabolismo , Nefropatías Diabéticas/patología , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Podocitos/metabolismo , Podocitos/patología , Polifenoles/química
2.
Diabetes ; 61(7): 1838-47, 2012 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-22586583

RESUMEN

The current study investigated the potential of green tea (GT) to improve uncoupling of endothelial nitric oxide synthase (eNOS) in diabetic conditions. In rats with streptozotocin-induced diabetes, nitric oxide (NO) bioavailability was reduced by uncoupling eNOS, characterized by a reduction in tetrahydrobiopterin (BH(4)) levels and a decrease in the eNOS dimer-to-monomer ratio. GT treatment ameliorated these abnormalities. Moreover, immortalized human mesangial cells (ihMCs) exposed to high glucose (HG) levels exhibited a rise in reactive oxygen species (ROS) and a decline in NO levels, which were reversed with GT. BH(4) and the activity of guanosine triphosphate cyclohydrolase I decreased in ihMCs exposed to HG and was normalized by GT. Exogenous administration of BH(4) in ihMCs reversed the HG-induced rise in ROS and the decline in NO production. However, coadministration of GT with BH(4) did not result in a further reduction in ROS production, suggesting that reduced ROS with GT was indeed secondary to uncoupled eNOS. In summary, GT reversed the diabetes-induced reduction of BH(4) levels, ameliorating uncoupling eNOS, and thus increasing NO bioavailability and reducing oxidative stress, two abnormalities that are involved in the pathogenesis of diabetic nephropathy.


Asunto(s)
Biopterinas/análogos & derivados , Camellia sinensis , Diabetes Mellitus Experimental/enzimología , Células Mesangiales/efectos de los fármacos , Óxido Nítrico Sintasa de Tipo III/metabolismo , Animales , Antioxidantes/farmacología , Biopterinas/análisis , Biopterinas/metabolismo , Células Cultivadas , Diabetes Mellitus Experimental/tratamiento farmacológico , GTP Ciclohidrolasa/metabolismo , Humanos , Células Mesangiales/enzimología , Óxido Nítrico/análisis , Óxido Nítrico/biosíntesis , Estrés Oxidativo/efectos de los fármacos , Ratas , Ratas Endogámicas SHR , Especies Reactivas de Oxígeno/análisis ,
3.
J Nutr ; 139(1): 96-100, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19056645

RESUMEN

Green tea (GT), through its antioxidant properties, may be useful to treat or prevent human diseases. Because several lines of evidence suggest that oxidative stress contributes to the pathogenesis of diabetic nephropathy, we tested the hypothesis that GT prevents diabetes and hypertension-related renal oxidative stress, attenuating renal injury. Spontaneously hypertensive rats (SHR) with streptozotocin-induced diabetes and nondiabetic SHR were treated daily with tap water or freshly prepared GT (13.3 g/L). After 12 wk, the systolic blood pressure did not differ between treated and untreated nondiabetic or diabetic rats. However, body weight was less (P < 0.05) and glycemia was greater in diabetic SHR rats than in nondiabetic rats. Renal oxidative stress variables such as 8-hydroxy-2'-deoxyguanosine (8-OHdG) and nitrotyrosine expression, NADPH oxidase-dependent superoxide generation, and the expression of renal cortex Nox4 were greater (P < 0.05) in diabetic rats that received water (DW) than in nondiabetic rats that received water (CW). The 8-OHdG and NADPH oxidase-dependent superoxide generation were significantly less in rats treated with GT. Nitrotyrosine and Nox4 expression were significantly less in diabetic rats that received GT (DGT) than in DW. Likewise, the indices of renal injury, albuminuria, and renal expression of collagen IV were significantly greater in DW than in CW. These differences were significantly less in DGT than in DW. GT reestablished the redox state and reduced the indicators of nephropathy without altering glycemia and blood pressure levels in diabetic SHR. These findings suggest that the consumption of GT may ameliorate nephropathy in diabetic hypertensive patients.


Asunto(s)
Camellia sinensis/química , Diabetes Mellitus Experimental/complicaciones , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Enfermedades Renales/prevención & control , NADPH Oxidasas/metabolismo , Extractos Vegetales/farmacología , Animales , Biomarcadores , Regulación hacia Abajo , Enfermedades Renales/complicaciones , NADPH Oxidasa 4 , NADPH Oxidasas/genética , Estrés Oxidativo , Extractos Vegetales/química , Ratas , Ratas Endogámicas SHR , Superóxidos/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA